secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0000950170-23-007359
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks discloses ~$74M exposure to failed Silicon Valley Bank via Zymergen subsidiary
--------------------------------------------------------------------------------

- Zymergen subsidiary holds ~$74M (6% of total cash) at Silicon Valley Bank.
- SVB closed and FDIC appointed receiver as of March 10, 2023.
- Company has no other material accounts or credit lines with SVB.
- Cash reference point: $74M based on Dec 31, 2022 balance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000095017023007359/0000950170-23-007359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000095017023007359/dna-20230301.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-007359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer